Status:
COMPLETED
The Influence of Endometrial Suturing on the Risk of Uterine Scar Defect
Lead Sponsor:
Sheba Medical Center
Conditions:
Cesarean Wound Disruption
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
Caesarean section (CS) is the commonest major operation performed on women worldwide with progressively rising incidence. Consequently, long-term adverse sequelae due to uterine scar defect have been ...
Detailed Description
Caesarean section (CS) is the commonest major operation performed on women worldwide with progressively rising incidence. Consequently, long-term adverse sequelae due to uterine scar defect have been ...
Eligibility Criteria
Inclusion
- Term pregnancy (≥37 weeks of gestation)
- Elective CS
Exclusion
- Uterine scar
- Thrombophilia
- Dysmorphic uterus
- Connective tissue disorder
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03851003
Start Date
May 1 2019
End Date
July 1 2022
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Aya Mohr-Sasson
Ramat Gan, Israel, 56506